Adgero Biopharmaceuticals Holdings, Inc. Note Agreements

10 Contracts & Agreements

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

8% Convertible Note, dated November 26, 2012, among Adgero Biopharmaceuticals, Inc. and Steven Rychnovsky, PhD

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NY

2017

8% Convertible Note, dated November 26, 2012, among Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NY

2017

Amendment to 6% Convertible Note, dated March 21, 2016, among Adgero Biopharmaceuticals, Inc. and Adam Stern

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NY

2017

6% Convertible Note, dated December 23, 2015, among Adgero Biopharmaceuticals, Inc. and Adam Stern

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NY

2017

Amendment to 6% Convertible Note, dated March 28, 2016, among Adgero Biopharmaceuticals, Inc. and Roman Perez-Soler, MD

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NY

2017

6% Convertible Note, dated October 28, 2015, among Adgero Biopharmaceuticals, Inc. and Roman Perez-Soler, MD

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NY

2017

Amendment to 6% Convertible Note, dated March 25, 2016, among Adgero Biopharmaceuticals, Inc. and Robert F. Hendrickson

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NY

2017

6% Convertible Note, dated October 6, 2015, among Adgero Biopharmaceuticals, Inc. and Robert F. Hendrickson

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NY

2017

Amendment to Promissory Note, dated December 30, 2015, among Adgero Biopharmaceuticals, Inc. and Frank Pilkiewicz, PhD

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

2017

Promissory Note, dated July 9, 2014, among Adgero Biopharmaceuticals, Inc. and Frank Pilkiewicz, PhD

Note Agreements

Adgero Biopharmaceuticals Holdings, Inc.

NJ

2017